EE425 Cost-Effectiveness Analysis of Rivaroxaban Vs Other Anticoagulants
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.673
https://www.valueinhealthjournal.com/article/S1098-3015(22)00874-9/fulltext
Title :
EE425 Cost-Effectiveness Analysis of Rivaroxaban Vs Other Anticoagulants
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00874-9&doi=10.1016/j.jval.2022.04.673
First page :
Section Title :
Open access? :
No
Section Order :
10603